Researcher.Life Logo

Farmakoekonomika : Impact Factor & More

eISSN: 2070-4933pISSN: 2070-4909
JournalOpen Access

Key Metrics

CiteScore
1
SNIP
0.28
Recommended pre-submission checks
Powered by Paperpal by Editage

Farmakoekonomika Journal Specifications

Overview
Publisher IRBIS LLC
Language Russian
Article Processing ChargesRUB 15000
Publication Time8
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicyCopyright Notice
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in Farmakoekonomika ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Farmakoekonomika

Neutrophil extracellular trap biomarkers as indicators of vulvovaginal atrophy severity after cancer treatment
  • 23 Dec 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
In silico modeling of the effects of SV-1010 candidate molecule interaction with opioid receptors
  • 23 Dec 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Assessment of nootropic drug assortment in the pharmaceutical sector of Uzbekistan
  • 2 Dec 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
On the issue of compounding drugs in pharmacies pursuant to physicians' prescriptions using a patented invention
  • 2 Dec 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Features of kidney structural changes in IgA-nephropathy with isolated detection of IgA class antibodies to deamidated gliadin peptides in the serum
  • 10 Nov 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Artificial intelligence in dermatology: a comparative analysis of computer vision programs based on machine learning models
  • 10 Nov 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Neutrophil extracellular trap biomarkers as indicators of vulvovaginal atrophy severity after cancer treatment
  • 23 Dec 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
In silico modeling of the effects of SV-1010 candidate molecule interaction with opioid receptors
  • 23 Dec 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Assessment of nootropic drug assortment in the pharmaceutical sector of Uzbekistan
  • 2 Dec 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
On the issue of compounding drugs in pharmacies pursuant to physicians' prescriptions using a patented invention
  • 2 Dec 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Features of kidney structural changes in IgA-nephropathy with isolated detection of IgA class antibodies to deamidated gliadin peptides in the serum
  • 10 Nov 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Artificial intelligence in dermatology: a comparative analysis of computer vision programs based on machine learning models
  • 10 Nov 2025
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

FAQs on Farmakoekonomika